High Levels of Inflammatory Biomarker Evident in Patients, Study Says, But Cause-Effect Unknown

Parkinson’s disease patients have “significantly elevated” levels of c-reactive protein, an acute-phase biomarker for inflammation in the body, according to a recent literature review. It remains to be understood, however, if c-reactive protein is a risk factor for this neurodegenerative disorder, or if the disease itself triggers an inflammatory…